These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 26861688)

  • 1. Mesostructured silica and aluminosilicate carriers for oxytetracycline delivery systems.
    Berger D; Nastase S; Mitran RA; Petrescu M; Vasile E; Matei C; Negreanu-Pirjol T
    Int J Pharm; 2016 Aug; 510(2):524-31. PubMed ID: 26861688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanostructure-loaded mesoporous silica for controlled release of coumarin derivatives: a novel testing of the hyperthermia effect.
    Al-Kady AS; Gaber M; Hussein MM; Ebeid el-ZM
    Eur J Pharm Biopharm; 2011 Jan; 77(1):66-74. PubMed ID: 20974253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of efficient quercetin delivery system on Zn-modified mesoporous SBA-15 silica carrier.
    Trendafilova I; Szegedi A; Mihály J; Momekov G; Lihareva N; Popova M
    Mater Sci Eng C Mater Biol Appl; 2017 Apr; 73():285-292. PubMed ID: 28183610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlling drug release from mesoporous silica through an amorphous, nanoconfined 1-tetradecanol layer.
    Mitran RA; Matei C; Berger D; Băjenaru L; Moisescu MG
    Eur J Pharm Biopharm; 2018 Jun; 127():318-325. PubMed ID: 29524598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The investigation of MCM-48-type and MCM-41-type mesoporous silica as oral solid dispersion carriers for water insoluble cilostazol.
    Wang Y; Sun L; Jiang T; Zhang J; Zhang C; Sun C; Deng Y; Sun J; Wang S
    Drug Dev Ind Pharm; 2014 Jun; 40(6):819-28. PubMed ID: 23594300
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of surface modified mesoporous materials via co-assemble route and their drug release properties.
    Wang Y; Zhu J; Han J; Guo R
    J Nanosci Nanotechnol; 2009 Nov; 9(11):6700-9. PubMed ID: 19908587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incorporation of antimicrobial compounds in mesoporous silica film monolith.
    Izquierdo-Barba I; Vallet-Regí M; Kupferschmidt N; Terasaki O; Schmidtchen A; Malmsten M
    Biomaterials; 2009 Oct; 30(29):5729-36. PubMed ID: 19628277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesoporous Silica-Bioglass Composite Pellets as Bone Drug Delivery System with Mineralization Potential.
    Szewczyk A; Skwira A; Konopacka A; Sądej R; Prokopowicz M
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33946793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interplay of Adsorption, Supersaturation and the Presence of an Absorptive Sink on Drug Release from Mesoporous Silica-Based Formulations.
    Hate SS; Reutzel-Edens SM; Taylor LS
    Pharm Res; 2020 Aug; 37(8):163. PubMed ID: 32754797
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adsorption and release of ampicillin antibiotic from ordered mesoporous silica.
    Nairi V; Medda L; Monduzzi M; Salis A
    J Colloid Interface Sci; 2017 Jul; 497():217-225. PubMed ID: 28285049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preparation and stability of β-carotene loaded using mesoporous silica nanoparticles as carriers system].
    Liu J; Ren ZH; Wang HY; Jin XH
    Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(18):3579-84. PubMed ID: 26983203
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supersaturation Potential of Ordered Mesoporous Silica Delivery Systems. Part 1: Dissolution Performance and Drug Membrane Transport Rates.
    Dening TJ; Taylor LS
    Mol Pharm; 2018 Aug; 15(8):3489-3501. PubMed ID: 29985627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradation-tunable mesoporous silica nanorods for controlled drug delivery.
    Park SB; Joo YH; Kim H; Ryu W; Park YI
    Mater Sci Eng C Mater Biol Appl; 2015 May; 50():64-73. PubMed ID: 25746247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carboxylic modified spherical mesoporous silicas аs drug delivery carriers.
    Popova MD; Szegedi Á; Kolev IN; Mihály J; Tzankov BS; Momekov GT; Lambov NG; Yoncheva KP
    Int J Pharm; 2012 Oct; 436(1-2):778-85. PubMed ID: 22884833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of New Bexarotene-loaded Mesoporous Silica Systems for Topical Pharmaceutical Formulations.
    Vasile A; Ignat M; Zaltariov MF; Sacarescu L; Stoleriu I; Draganescu D; Dumitras M; Ochiuz L
    Acta Chim Slov; 2018 Mar; 65(1):97-107. PubMed ID: 29562115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mesoporous silica-based nanomaterials for drug delivery: evaluation of structural properties associated with release rate.
    Strømme M; Brohede U; Atluri R; Garcia-Bennett AE
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(1):140-148. PubMed ID: 20049785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of novel core-shell dual-mesoporous silica nanoparticles for the production of high bioavailable controlled-release fenofibrate tablets.
    Zhao Z; Gao Y; Wu C; Hao Y; Zhao Y; Xu J
    Drug Dev Ind Pharm; 2016; 42(2):199-208. PubMed ID: 26114553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of magnetic FexOy@silica-pillared clay (SPC) composites via a novel sol-gel route for controlled drug release and targeting.
    Mao H; Liu X; Yang J; Li B; Yao C; Kong Y
    Mater Sci Eng C Mater Biol Appl; 2014 Jul; 40():102-8. PubMed ID: 24857471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of Drug-Silica Electrostatic Interactions on Drug Release from Mesoporous Silica-Based Oral Delivery Systems.
    Hate SS; Reutzel-Edens SM; Taylor LS
    Mol Pharm; 2020 Sep; 17(9):3435-3446. PubMed ID: 32790416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chiral mesoporous silica based LOFL delivery systems using achiral alcohols as co-structure-directing agents: Construction, characterization, sustained release and antibacterial activity.
    Cui M; Xie L; Zhang S; Chen L; Xi Y; Wang Y; Guo Y; Xu L
    Colloids Surf B Biointerfaces; 2019 Dec; 184():110483. PubMed ID: 31522027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.